Form 4: Eli Casdin Reports Changes in Beneficial Ownership of GeneDx Holdings Corp. (WGS)

Eli Casdin, a director and 10% owner of GeneDx Holdings Corp., reports changes in beneficial ownership of Class A Common Stock and Restricted Stock Units (RSUs) following the vesting of RSUs.

Summary

• Eli Casdin, a director and 10% owner of GeneDx Holdings Corp. (WGS), filed a Form 4 detailing changes in beneficial ownership.
• On June 20, 2024, 5,828 Restricted Stock Units (RSUs) vested, each representing a contingent right to receive one share of Class A Common Stock.
• Following the transaction, Mr. Casdin directly owns 7,593 shares of Class A Common Stock.
• Mr. Casdin also has indirect beneficial ownership of shares held by CMLS Holdings LLC (333,144 shares), Casdin Partners F01-MSV, LP (432,902 shares), and Casdin Partners Master Fund, LP (3,093,509 shares).
• Mr. Casdin disclaims beneficial ownership of shares held by CMLS Holdings LLC, Casdin Partners F01-MSV, LP, and Casdin Partners Master Fund, LP, except to the extent of his pecuniary interest therein.
• The RSUs vest the earlier of the date of the next annual meeting of the Issuer's shareholders following the grant date, and the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure related to changes in beneficial ownership by a company insider. It is a standard practice for directors and officers of publicly traded companies.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the ownership structure of the company.
• The vesting of RSUs may have a minor dilutive effect on existing shareholders.

Key Dates